How long has it been since you learned something new about cannabis? How long has it been since you heard of another cannabinoid other than THC and CBD? Information is lacking and research is being bureaucratically delayed. But thankfully, this is all changing. The widespread legalization in the US and countries around the world is motivating discoveries in the realm of cannabis.

Before we get any deeper, an introduction to the term “phytocannabinoids” is urgently necessary. While endocannabinoids are your body’s naturally produced cannabinoids, phytocannabinoids are the ones found in plants like cannabis. These include your well-known THC and CBD. The 100+ different phytocannabinoids in your weed share similar properties to the cannabinoids naturally produced in your body. They bind to the receptors spread out all throughout the human body, brain, nervous system and immune system. This is what gives you the traditional cannabis “high”.

This is already hard enough to understand, but to add to the complication, cannabinoids have different effects when working together. This depends on the density that a strain had of each one. THC, for example, has shown stronger effects when CBD’s presence is decreased and vice versa. This is called the entourage effect (yes, like the movie).

It was only in the past decade that many phytocannabinoids have been discovered, and amongst them is CBDV. This is a non-psychoactive cannabinoid like its cousin CBD. It has shown to be useful in a wide range of therapeutic and medical conditions. Not only as a treatment but also as an aid for dealing with existing medication.



Recent research[1] is showing the medical potential of CBDV to treat epilepsy and other neurological conditions. With human testing yet to come, this cannabinoid has shown to be an effective anticonvulsant and antiepileptic in mice studies.

These findings are not mere speculation. Justin Gover, CEO of GW Pharmaceuticals stated: “This patent is important as we believe that CBDV has the potential to become an important new treatment option in the field of epilepsy”. This when answering in regards to an already filed patent for the use CBDV as a treatment for seizures.

The University of Reading, in London, also stated that CBD and CBDV show significant anti-epileptic and anti-seizure properties.

A seizure has many symptoms, of which convulsions are amongst the most worrying and common ones. Not only does CBDV come to aid in the prevention of seizures, but a study has also shown that it helps prevent convulsions. Meaning that even if a patient goes into an epileptic seizure, they might not experience convulsions with the aid of this cannabinoid.

None of these studies are conclusive. Most, if not all, stress the need for further and more in-depth research. But the fact that a hypothesis like this is even being discussed, is extremely positive for the cannabis world.


It’s no secret that the “munchies” is amongst the, if not the, most popular symptom of cannabis out there. We have all gone through an entire bag of chips only to realise that we still feel empty and in need of a trip to McDonald’s ASAP. So, the connection between cannabis and our digestive system is already common knowledge. What if we told you that CBDV alone works as a “munchie repellent”?

A 2012 study[2] has shown CBDV to be an appetite suppressant without the secondary effects common to most pharmaceuticals prescribed for similar conditions. Maybe in the future, we’ll be able to cure obesity or at least help decrease it with a CBDV extract.

The University of Guelph, in Guelph, Canada, looked at how THCV and CBDV work in reducing nausea. The results[3] were extremely positive, yet, the study still concluded that more research was needed in order to determine the best way to use CBDV in this treatment. Cannabis is already known to help cancer patients deal with this consequence of their medication. But hopefully, in the future, we might find a much more effective and efficient way to use this cannabinoid.

It is important to stress that CBDV is NOT a treatment nor a medicine. It holds potential, but to what extent and how it can be properly utilised is not known.


CBDV is most common amongst landrace indica strains. Landrace are the genetically pure strains. These are the ones whose genetics weren’t influenced by human experimentation. They evolved alongside nature, which is always the best way. Another great way of obtaining CBDV is extracting it from hemp. By legal definition, this cousin to cannabis contains less than 0.3% THC. A good hemp strain can have up to a 100:1 ratio CBD-to-THC. This helps immensely those trying to medicate their children.

As mentioned above, CBDV will be more present in low-THC and high-CBD strains. These include sativas like Dance World, Royal Medic and Painkiller XL. As well as indicas like Euphoria and Medical Mass.

So now that you are a little more informed about this cannabinoid, make sure to spread the information. The cannabis community suffers from a lot of things but especially from the passing of wrong information. Try to educate your friends and close ones. You might even have a family member who could benefit from this specific compound. Don’t be afraid to suggest cannabis as a medication. You might be frown upon at first, but the benefits will speak for themselves in the future.

External Resources:
  1. Cannabidivarin‐rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor‐independent mechanism
  2. Anti-Obesity Drugs: A Review about Their Effects and Safety
  3. Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor invers... - PubMed - NCBI
This content is for educational purposes only. The information provided is derived from research gathered from external sources.

Are you aged 18 or over?

The content on is only suitable for adults and is reserved for those of legal age.

Ensure you are aware of the laws of your country.

By clicking ENTER, you confirm
you are
18 years or older